Standpunkt MedTech 2026: A Confident Industry Balancing Economic Strength and New Challenges in Healthcare Delivery
How does Germany’s medical technology industry measure up against international competition? What health policy priorities need to be set? And what challenges arise from the growing shift towards outpatient care? These questions were at the heart of “Standpunkt · Medtech”, an event hosted by BioRegio STERN Management GmbH and Medical Valley Hechingen e. V. on 9 November 2026. Around 70 participants from the medical technology sector gathered at the Fundera Business Forum in Hechingen to discuss current developments, economic prospects and the future of patient care.
The event offered insights into the current state of the medical technology sector from two different perspectives: while the Managing Director of the German Medical Technology Association (BVMed) examined the industry’s economic and regulatory framework, the Deputy Managing Director of Verband Versorgungsqualität Homecare e. V. focused on the challenges posed by the growing shift towards outpatient care. The subsequent panel discussion brought these perspectives together and complemented them with practical business experience.
Before the official programme began, participants had the opportunity to explore the Fundera Business Forum on a guided tour. The event was opened by Peter Barthold, Managing Director of Medical Valley Hechingen e. V.; Philipp Hahn, Mayor of Hechingen; Dr Steffen Hüttner, Chairman of the Association for the Promotion of Biotechnology and Medical Technology; and Egon Wiest, founder and Managing Director of medical device manufacturer ewimed GmbH. Dr Klaus Eichenberg, Managing Director of BioRegio STERN Management GmbH, moderated the event.
Peter Barthold | Geschäftsführer des Medical Valley Hechingen e. V.
/ Copyright: Christoph Schmidt/ BioRegio STERN Management GmbHPhilipp Hahn, Bürgermeister der Stadt Hechingen
/ Copyright: Christoph Schmidt/ BioRegio STERN Management GmbHDr. Steffen Hüttner | Vorsitzender des Vereins zur Förderung der Biotechnologie und Medizintechnik e. V.
/ Copyright: Christoph Schmidt/ BioRegio STERN Management GmbHEgon Wiest, Gründer und Geschäftsführer des Medizintechnik-Herstellers ewimed GmbH
/ Copyright: Christoph Schmidt/ BioRegio STERN Management GmbHDie Teilnehmer wurden in Gruppen durch das Fundera Business Forum geführt
/ Copyright: Christoph Schmidt/ BioRegio STERN Management GmbHBei der Führung durch das Fundera Business Forum
/ Copyright: Christoph Schmidt/ BioRegio STERN Management GmbHMedical Technology as a Leading Industry: Economic Strength and Political Challenges
In his presentation, “Between Berlin, Brussels and MedTech – What Really Matters to the Industry”, Dr Marc-Pierre Möll, Managing Director of BVMed e. V., analysed the current state of Germany’s medical technology sector and its position in international competition.
Despite challenging economic conditions, the industry remains resilient. According to the industry data presented, Germany is the world’s second-largest producer of medical technology and has a strong industrial base. Medical technology is also gaining political prominence, with growing recognition of its role as one of the German economy’s key industries and drivers of innovation.
Dr. Marc-Pierre Möll, Geschäftsführer des BVMed e. V.
/ Copyright: Christoph Schmidt/ BioRegio STERN Management GmbH
Dr. Klaus Eichenberg | Geschäftsführer der BioRegio STERN Management GmbH
/ Copyright: Christoph Schmidt/ BioRegio STERN Management GmbH“The industry is projecting confidence,” Dr Klaus Eichenberg said, summing up the mood.
Yet economic strength alone is not enough to safeguard long-term international competitiveness. A reliable regulatory framework and health policies that address the specific needs of the medical technology sector are equally crucial. The European Medical Device Regulation (MDR) plays an important role in this context, with changes already being set in motion.
The discussion also highlighted the importance of a dedicated MedTech strategy. Its consistent implementation, together with the industry’s early involvement in health policy reforms, is essential to sustainably strengthen innovation, competitiveness and the reliable provision of care.
The Shift Towards Outpatient Care: Why Care at Home Requires More Than Innovative Products
Dennis Giesfeldt, Deputy Managing Director of Verband Versorgungsqualität Homecare e. V., offered a different but equally important perspective on the future of medical technology. His presentation, “Where Is Outpatient Care Heading? Healthcare Is Coming Home – Or Is It?”, explored how medical care outside inpatient facilities could be organised in the future.
The shift towards outpatient care is seen as a key element in preparing the healthcare system for demographic change and growing care needs. In practice, however, significant barriers remain.
One key figure illustrates just how important care at home already is: around 86 percent of people in Germany who require long-term care are cared for at home. Care provided by family members or managed by those affected themselves is therefore no longer the exception, but the norm.
Dennis Giesfeldt | stellvertr. Geschäftsführer des Verbands Versorgungsqualität Homecare e. V.
/ Copyright: Christoph Schmidt/ BioRegio STERN Management GmbHOne of the presentation’s key findings was that the problem is often not a lack of medical treatment options, but a lack of effective care pathways that enable continuous, high-quality care at home.
Medical technology companies also have an important role to play here. What matters is not just a medical device’s technical capabilities, but how it fits into the overall care pathway. For innovative solutions to deliver their full benefits, the product must be accompanied by appropriately trained users, thorough instruction and reliable support in day-to-day care.
For the industry, this means aligning the development of new technologies even more closely with the actual requirements of patient care. An innovative medical device does not automatically improve care – only its appropriate and safe use translates medical advances into tangible benefits for patients.
Different Perspectives, Shared Challenges
In the subsequent panel discussion, Peter Barthold, Dennis Giesfeldt, Dr Marc-Pierre Möll and Egon Wiest explored the viewpoints presented in greater depth. Health policy and regulatory issues were considered alongside perspectives from care delivery and medical technology companies.
The discussion highlighted how closely the industry’s economic development is linked to structural changes in the healthcare system. While medical technology has considerable potential as a driver of innovation, its practical benefits also depend on how effectively regulatory requirements, care structures and real-world application work together.
Podiumsdiskussion auf der Bühne
/ Copyright: Christoph Schmidt/ BioRegio STERN Management GmbHDennis Giesfeldt im Podium
/ Copyright: Christoph Schmidt/ BioRegio STERN Management GmbHBei der Podiumsdiskussion
/ Copyright: Christoph Schmidt/ BioRegio STERN Management GmbHThe discussions also highlighted the importance of direct dialogue between industry, associations and other healthcare stakeholders. Conversations continued well beyond the official programme, with participants sharing experiences and examining the challenges raised from different perspectives.
With “Standpunkt · Medtech”, BioRegio STERN Management GmbH and Medical Valley Hechingen e. V. once again provided a forum for an in-depth examination of economic and health policy developments in medical technology. The event made one thing clear: the industry is looking to the future with confidence. Yet translating its innovative strength more effectively into high-quality patient care requires not only new technologies, but also the right political and structural conditions.
V.l.n.r.: Egon Wiest, Philipp Hahn, Thomas Bogenschütz, Dr. Klaus Eichenberg, Dr. Steffen Hüttner, Peter Barthold, Dr. Marc-Pierre Möll, Dennis Giesfeldt
/ Copyright: Christoph Schmidt/ BioRegio STERN Management GmbHBeim Networking
/ Copyright: Christoph Schmidt/ BioRegio STERN Management GmbHBeim Networking
/ Copyright: Christoph Schmidt/ BioRegio STERN Management GmbHInfoflyer 2026
You can find the event details and agenda here.
BioRegio STERN Management GmbH